Re:In its fight to keep drug prices high, big pharma leans o...
by munk-a on Monday April 29, 2019 @04:12PM
(#19782158)
Research is expensive and quite risky, drug research especially. R&D investment by companies into more efficient manufacturing are definitely good things to let the free-market do as it will with - but drug innovation is currently highly subsidized by the government, and my hope is that it ends up being transitioned to being entirely subsidized. It's an academic pursuit so we want to encourage experimentation without personal financial risk - solving the problem by just remitting enough money to the pharma industry (in the form of unnegotiated prices leading to wild profits) is a highly inefficient allocation - there is no guarantee that a company will reinvest those profits into radical research (many times they won't instead preferring business concerns like a high dividend yield or stock buy backs to cement contained wealth) and, since the government is already subsidizing a lot of research, the "correct" move from a profit perspective is to avoid innovation costs and just focus on snapping up any new discoveries coming out of academia.
Re:In its fight to keep drug prices high, big pharma leans o...
by refurb on Monday April 29, 2019 @05:07PM
(#19782630)
New discoveries coming out of academia are lucky if they are a decade and hundreds of millions of dollars away from being an actual drug. Usually what comes out of academia is an idea or starting point, not a drug.
And no, drug innovation is not highly subsidized by the gov't. Just look at budgets. NIH budget is $38B, of which a fraction is actually spent on research leading to new drugs. PhRMA (just the largest drug companies) spent $71B in 2017.[1] And that ignores the billions spent by VCs to fund start-ups, another $13B in the first 10 months of 2017.[2]
Adding it up, private spending on drug R&D is probably 5-10x that of what the gov't spends.
[1]https://www.biopharmadive.com/news/phrma-research-developmen... [2]http://www.pharmatimes.com/magazine/2018/december_2018/a_rec...
Their research is no paid for by the US gov't. Basic research is heavily subsidized, but basic research doesn't get you a drug and basic research is the cheapest part of the entire process. They are still shoving billions of dollars into bringing drugs to market, again, often not successfully.